Skip to main content
Caplight Logo









Astraea

Astraea

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.tryastraea.com/

Last Round

M&A

Feb 20, 2024

Total Funding Raised

$13.5M

Company Overview

Astraea is a healthcare technology company that provides an AI-native platform for automating clinical trial biometrics, data management, and regulatory submission workflows.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Workflow Automation, Compliance, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

clinical trial biometricsbiometrics automationclinical trial automationclinical data pipelineCDISCSDTMADaMAI agentregulatory submissionclinical trial softwareAI-native platformvertical SaaSTFL generationpharma techbiotech AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Astraea Comparables

Compare Astraea with similar companies based on industry and business-model similarity.

Astraea comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Readout AI
87%
Verisian
82%
Hill Research
82%

Astraea Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AFeb 20, 2024
Series AJul 21, 2022
SeedSep 1, 2020

Key People

Founding team and executive leadership

Joshua Wang

Co-Founder & CEO

Founding Team

Astraea Investors

Notable investors and investment history

Astraea investors
InvestorRounds
University of Virginia LVG Seed FundSeed, Series A
CAV AngelsSeed, Series A
Aligned Climate CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 21, 2022

    $7M round led by Aligned Climate Capital.

  • Sep 1, 2020

    $7M raised from University of Virginia LVG Seed Fund and CAV Angels.

Astraea Filings

Explore SEC and related filing metadata, where available.

Astraea filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Astraea's valuation, stock price, and market status.

Is Astraea a public or private company?

Astraea is a private company.

What is the current stock price of Astraea?

Astraea is a private company with no public stock price. No recent secondary market data is available.

How much is Astraea worth (valuation)?

Valuation information for Astraea is not publicly available.

Can I buy Astraea stock?

Astraea shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Astraea's last funding round?

Astraea's most recent funding round was M&A on February 20, 2024.

Who are the main investors in Astraea?

Key investors in Astraea include Aligned Climate Capital.

Will Astraea IPO soon?

No public IPO plans have been announced for Astraea.

How can I track Astraea secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Astraea's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range3
Year Founded2026
Last FundingFeb 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?